ESSA PHARMA INC's ticker is and the CUSIP is 29668H104. A total of 10 filers reported holding ESSA PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $8,000 | – | 28,642 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clarus Ventures, LLC | 2,121,212 | $5,833,000 | 3.58% |
| Omega Fund Management, LLC | 1,696,969 | $4,667,000 | 3.56% |
| AWM Investment Company, Inc. | 1,696,968 | $4,785,000 | 0.88% |
| ACUTA CAPITAL PARTNERS, LLC | 586,700 | $1,678,000 | 0.63% |
| DAFNA Capital Management LLC | 195,496 | $733,000 | 0.51% |
| Eventide Asset Management | 2,719,410 | $6,828,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,121,601 | $5,834,000 | 0.27% |
| Boxer Capital, LLC | 28,100 | $74,000 | 0.03% |
| ROYAL BANK OF CANADA | 4,200 | $12,000 | 0.00% |
| Evercore Wealth Management, LLC | 5,670 | $0 | 0.00% |